Showing 611-620 of 2332 results for "".
Cryptogenic Stroke & Atrial Fibrillation: Establishing the Link Through Team Approaches to Care
https://practicalneurology.com/diseases-diagnoses/stroke/cryptogenic-stroke--atrial-fibrillation-establishing-the-link-through-team-approaches-to-care/30393/Implementing a Cryptogenic Stroke Pathway may help reduce recurrent strokes and improve outcomes for stroke patients.Alpha-Synuclein: A Therapeutic Target and Potential Biomarker in Parkinson's Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/alpha-synuclein-a-therapeutic-target-and-potential-biomarker-in-parkinsons-disease/30407/Comprehensive Stroke Certification What Does Does it Take?
https://practicalneurology.com/diseases-diagnoses/stroke/comprehensive-stroke-certification-what-does-does-it-take/30704/The Ochsner Medical Center ExperienceTics and Tourette Syndrome
https://practicalneurology.com/diseases-diagnoses/child-neurology/tics-and-tourette-syndrome/30330/Recognizing the full spectrum of phenomenology of tics and various behavioral comorbidities is critical to diagnosis.A Survey of Neurologists on Career Satisfaction and Burnout
https://practicalneurology.com/columns/practice-management/a-survey-of-neurologists-on-career-satisfaction-and-burnout/30707/Onabotulinumtoxin in the Preventive Treatment of Chronic Migraine and Other Headaches
https://practicalneurology.com/diseases-diagnoses/headache-pain/onabotulinumtoxin-in-the-preventive-treatment-of-chronic-migraine-and-other-headaches/30833/While BoNTA shows promise in the management of chronic migraine, optimal outcomes will be acheived when clinicians learn which patients are most likely to benefit.The Health Care Debate: What Will It Mean For You?
https://practicalneurology.com/columns/practice-management/PN0909_01-php/30887/The changes proposed in Congress could mean big changes to your practice. We take a look at how things could play out.- Therapeutics Q&Ahttps://practicalneurology.com/columns/practice-management/therapeutics-qa/31019/Optimizing Restless Legs Syndrome Treatment: Insights from Recent Meta-Analysis and Clinical ExperiencesA recent meta-analysis evaluating the side effects and wearing-off effects of four Restless Legs Syndrome (RLS) medications highlighted significant findings relevant to clinical practice. The stud
- Second Opinionshttps://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/PN0505SecondOpinion-pdf/31458/Addressing the AD-VaD Diagnostic Challenge in NeurologyIn the debate surrounding Alzheimer’s Disease (AD) versus vascular dementia (VaD) diagnosis, Dr. Geldmacher’s April 2005 article, “Diagnosing Alzheimer’s: Easy Answers vs. Right Answers,” ignited significant discourse. Dr. Geldmacher critiques c
Single Isolated Concussion Part I: Definitions, Classification, and Prognosis
https://practicalneurology.com/diseases-diagnoses/tbi/single-isolated-concussion-part-i-definitions-classification-and-prognosis/30268/Providing sound advice after a single isolated concussion.